295 related articles for article (PubMed ID: 24002891)
21. High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.
Xiao W; Ma W; Wei S; Li Q; Liu R; Carney RP; Yang K; Lee J; Nyugen A; Yoneda KY; Lam KS; Li T
J Hematol Oncol; 2019 Jun; 12(1):56. PubMed ID: 31182116
[TBL] [Abstract][Full Text] [Related]
22. Glycosylation of the laminin receptor (α3β1) regulates its association with tetraspanin CD151: Impact on cell spreading, motility, degradation and invasion of basement membrane by tumor cells.
Ranjan A; Bane SM; Kalraiya RD
Exp Cell Res; 2014 Apr; 322(2):249-64. PubMed ID: 24530578
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.
Giannelli G; Fransvea E; Marinosci F; Bergamini C; Colucci S; Schiraldi O; Antonaci S
Am J Pathol; 2002 Jul; 161(1):183-93. PubMed ID: 12107103
[TBL] [Abstract][Full Text] [Related]
24. Changes in adhesive and migratory characteristics of hepatocellular carcinoma (HCC) cells induced by expression of alpha3beta1 integrin.
Mizuno H; Ogura M; Saito Y; Sekine W; Sano R; Gotou T; Oku T; Itoh S; Katabami K; Tsuji T
Biochim Biophys Acta; 2008 Mar; 1780(3):564-70. PubMed ID: 17997226
[TBL] [Abstract][Full Text] [Related]
25. TGF-β1 regulates the invasive and metastatic potential of mucoepidermoid carcinoma cells.
Wang J; Chen J; Zhang K; Zhao Y; Nör JE; Wu J
J Oral Pathol Med; 2011 Nov; 40(10):762-8. PubMed ID: 21689159
[TBL] [Abstract][Full Text] [Related]
26. Complementary DNA arrays identify CD63 tetraspanin and alpha3 integrin chain as differentially expressed in low and high metastatic human colon carcinoma cells.
Sordat I; Decraene C; Silvestre T; Petermann O; Auffray C; Piétu G; Sordat B
Lab Invest; 2002 Dec; 82(12):1715-24. PubMed ID: 12480921
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell adhesion and invasion in glioma.
Rao Malla R; Gopinath S; Alapati K; Gorantla B; Gondi CS; Rao JS
Mol Carcinog; 2013 Oct; 52(10):777-90. PubMed ID: 22495828
[TBL] [Abstract][Full Text] [Related]
28. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
[TBL] [Abstract][Full Text] [Related]
29. CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.
Zhou P; Erfani S; Liu Z; Jia C; Chen Y; Xu B; Deng X; Alfáro JE; Chen L; Napier D; Lu M; Huang JA; Liu C; Thibault O; Segal R; Zhou BP; Kyprianou N; Horbinski C; Yang XH
Oncotarget; 2015 Oct; 6(30):29675-93. PubMed ID: 26377974
[TBL] [Abstract][Full Text] [Related]
30. Adhesion of gastric carcinoma cells to peritoneum mediated by alpha3beta1 integrin (VLA-3).
Takatsuki H; Komatsu S; Sano R; Takada Y; Tsuji T
Cancer Res; 2004 Sep; 64(17):6065-70. PubMed ID: 15342388
[TBL] [Abstract][Full Text] [Related]
31. The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk.
Arpaia E; Blaser H; Quintela-Fandino M; Duncan G; Leong HS; Ablack A; Nambiar SC; Lind EF; Silvester J; Fleming CK; Rufini A; Tusche MW; Brüstle A; Ohashi PS; Lewis JD; Mak TW
Oncogene; 2012 Feb; 31(7):884-96. PubMed ID: 21765460
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of cell invasion and matrix metalloproteinase production by alpha3beta1 integrin-mediated adhesion of gastric carcinoma cells to laminin-5.
Saito Y; Sekine W; Sano R; Komatsu S; Mizuno H; Katabami K; Shimada K; Oku T; Tsuji T
Clin Exp Metastasis; 2010 Apr; 27(4):197-205. PubMed ID: 20352300
[TBL] [Abstract][Full Text] [Related]
33. Receptor tyrosine kinase Met promotes cell survival via kinase-independent maintenance of integrin α3β1.
Tesfay L; Schulz VV; Frank SB; Lamb LE; Miranti CK
Mol Biol Cell; 2016 Aug; 27(15):2493-504. PubMed ID: 27307589
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of human laminin-8. Laminin-8 stimulates cell adhesion and migration through alpha3beta1 and alpha6beta1 integrins.
Fujiwara H; Kikkawa Y; Sanzen N; Sekiguchi K
J Biol Chem; 2001 May; 276(20):17550-8. PubMed ID: 11278628
[TBL] [Abstract][Full Text] [Related]
35. The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer.
Hauser AD; Bergom C; Schuld NJ; Chen X; Lorimer EL; Huang J; Mackinnon AC; Williams CL
Mol Cancer Res; 2014 Jan; 12(1):130-42. PubMed ID: 24197117
[TBL] [Abstract][Full Text] [Related]
36. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J
Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248
[TBL] [Abstract][Full Text] [Related]
37. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
38. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
[TBL] [Abstract][Full Text] [Related]
39. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
40. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
